Ex Parte Chen et al - Page 10

                  Appeal 2007-1073                                                                                           
                  Application 10/308,176                                                                                     

                  combine MIGLYOL 812 and tocopherol PEG-1000 succinate in the form of                                       
                  a composition comprising about 50% of each.                                                                
                         In view of the above, the rejection of the claims for obviousness                                   
                  is reversed.                                                                                               

                                                       SUMMARY                                                               
                         The rejection of claims 104-108 under 35 U.S.C. § 112, first                                        
                  paragraph, as containing new matter is reversed.   The indefiniteness                                      
                  rejection of the claims is reversed.   The obviousness rejection of the claims                             
                  is reversed.                                                                                               
                                                       REVERSED                                                              




                  lbg                                                                                                        




                  STERNE, KESSLER, GOLDSTEIN & FOX PLLC                                                                      
                  1100 NEW YORK AVENUE, N.W.                                                                                 
                  WASHINGTON, DC 20005                                                                                       








                                                             10                                                              

Page:  Previous  1  2  3  4  5  6  7  8  9  10

Last modified: September 9, 2013